The U.S. Department of Justice (DOJ) and 18 state attorneys general (AG) announced a settlement with Boston-based QOL Medical, LLC (QOL) and its ...
Hosted on MSN2mon
Pharmaceutical company to pay $47M for false federal health claimsSucraid is an FDA-approved therapy for the rare genetic condition Congenital Sucrase-Isomaltase Deficiency (CSID), but it comes with a hefty price tag. QOL and Cooper have admitted that they ...
This genetic variation—enzymatic sucrase-isomaltase (SI) deficiency—could lead to dietary sugars remaining undigested by the ...
MassHealth receives $1.4 million from a $47 million settlement with QOL Medical over alleged kickback schemes involving ...
According to research, taking the supplement can help enhance digestion and easy gut problems like bloating, gas and stomach aches ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results